Cytokinetics Inc (CYTK) — Financial Flexibility Index
Cytokinetics Inc (CYTK) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of $-139.53 Million (operating CF $-145.46 Million minus capex $5.93 Million) represents 0% of total liabilities ($2.10 Billion). Check strategic asset allocation of Cytokinetics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytokinetics Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Cytokinetics Inc across 24 annual periods. See Cytokinetics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cytokinetics Inc (2002–2025)
Year-by-year free cash flow to debt coverage for Cytokinetics Inc. For the full company profile including market capitalisation, see Cytokinetics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-485.20 Million | $-510.01 Million | $2.08 Billion | ▲ +8.7% |
| 2024 | -0.26x | $-391.98 Million | $-395.89 Million | $1.54 Billion | ▲ +25.2% |
| 2023 | -0.34x | $-412.92 Million | $-414.33 Million | $1.21 Billion | ▼ -32.9% |
| 2022 | -0.26x | $-288.18 Million | $-299.52 Million | $1.12 Billion | ▼ -63.8% |
| 2021 | -0.16x | $-93.65 Million | $-142.52 Million | $597.46 Million | ▼ -429.6% |
| 2020 | 0.05x | $20.00 Million | $8.94 Million | $420.42 Million | ▲ +116.2% |
| 2019 | -0.29x | $-88.29 Million | $-90.91 Million | $300.75 Million | ▲ +45.8% |
| 2018 | -0.54x | $-100.33 Million | $-101.22 Million | $185.24 Million | ▼ -1.3% |
| 2017 | -0.53x | $-98.88 Million | $-101.76 Million | $184.97 Million | ▼ -205.0% |
| 2016 | 0.51x | $38.58 Million | $36.98 Million | $75.78 Million | ▲ +336.1% |
| 2015 | 0.12x | $5.45 Million | $4.88 Million | $46.65 Million | ▲ +110.9% |
| 2014 | -1.07x | $-43.74 Million | $-44.84 Million | $40.90 Million | ▼ -328.3% |
| 2013 | -0.25x | $-7.18 Million | $-7.72 Million | $28.75 Million | ▲ +95.4% |
| 2012 | -5.45x | $-33.31 Million | $-33.44 Million | $6.11 Million | ▲ +44.5% |
| 2011 | -9.83x | $-45.15 Million | $-45.59 Million | $4.59 Million | ▼ -65.7% |
| 2010 | -5.93x | $-44.34 Million | $-44.83 Million | $7.48 Million | ▼ -1500.3% |
| 2009 | 0.42x | $8.97 Million | $8.42 Million | $21.17 Million | ▲ +126.3% |
| 2008 | -1.61x | $-60.67 Million | $-61.33 Million | $37.69 Million | ▼ -20096.8% |
| 2007 | -0.01x | $-442.00K | $-3.00 Million | $55.45 Million | ▲ +98.8% |
| 2006 | -0.66x | $-41.80 Million | $-47.17 Million | $63.20 Million | ▲ +68.9% |
| 2005 | -2.12x | $-38.02 Million | $-39.48 Million | $17.90 Million | ▼ -33.7% |
| 2004 | -1.59x | $-32.63 Million | $-34.03 Million | $20.55 Million | ▼ -795.9% |
| 2003 | -0.18x | $-27.46 Million | $-30.51 Million | $154.90 Million | ▼ -31.6% |
| 2002 | -0.13x | $-15.73 Million | $-22.30 Million | $116.76 Million | — |